CN109917036A - Gentamicin procaine ties up the HPLC-ELSD detection method of gentamicin C components content in B12 capsule - Google Patents
Gentamicin procaine ties up the HPLC-ELSD detection method of gentamicin C components content in B12 capsule Download PDFInfo
- Publication number
- CN109917036A CN109917036A CN201910230015.XA CN201910230015A CN109917036A CN 109917036 A CN109917036 A CN 109917036A CN 201910230015 A CN201910230015 A CN 201910230015A CN 109917036 A CN109917036 A CN 109917036A
- Authority
- CN
- China
- Prior art keywords
- gentamicin
- content
- capsule
- component
- procaine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention belongs to field of chemical detection, more particularly to the HPLC-ELSD detection method of gentamicin C components content in a kind of gentamicin procaine dimension B12 capsule, including (1) chromatographic condition and system suitability (2) solution prepare (3) measurement.This method is easy to operate, detection efficiency is high, error is small, the method of inspection is more stable, accuracy, precision, specificity, detection limit, durability of this method etc. meet methodology validation requirement, with very strong practicability, the content of gentamicin C components in gentamicin procaine dimension B12 capsule can be quickly detected, thus the effectively quality of control gentamicin procaine dimension B12 capsule.
Description
Technical field
The invention belongs to field of chemical detection, and in particular to celebrating is big mould in a kind of gentamicin procaine dimension B12 capsule
The HPLC-ELSD detection method of plain component C content.
Background technique
Gentamicin procaine dimension B12 capsule (former name gastritis capsule also known as gentamicin procaine capsule, with
The compound mouth being made of gentamicin sulphate, procaine hydrochloride, vitamin B12 and appropriate amount of auxiliary materials down referred to as " capsule "))
Formulation.Wherein, gentamicin sulphate is aminoglycoside antibiotics, to various gram-negative bacterias, gram-positive bacteria and
Helicobacter pylori has antibacterial action, can inhibit helicobacter pylori, plays local bactericidal effect under one's belt;Hydrochloric acid Proca
For local anaesthetics, sealing process can be played to the nerve endings on damaging mucosal surface, block the stimulation of lesion Central nervous system, from
And rapid pain relief;Vitamin B12 is substance necessary to form alimentary canal normal epithelium cell.Three's cooperation can be played anti-
Bacterium, analgesic and the effect for promoting gastric mucosal, are used clinically for alleviating acute and chronic gastritis symptom and anti-inflammatory, analgesic, promotion
Stomach lining reparation.
Gentamicin procaine ties up B12 capsule current standard as the rising of " national drug standards " chemicals provincial standard
National standard (the 6th) WS-10001-(HD-0524) -2002, State Food and Drug Administration standard YBH15222004
With State Food and Drug Administration standard YBH20972006, the detection in three parts of standards for gentamicin sulphate has
The identification (WS-10001-(HD-0524) -2002 of sulfate), thin layer identify (YBH15222004, YBH20972006) and
Assay, the Con trolling index without its component.Gentamicin sulphate is aminoglycoside antibiotics, is with gentamicinC1、C1a、
C2、C2aEtc. mixture based on components, no UV absorption.Main pharmacodynamics ingredient one of of the gentamicin sulphate as this product, mark
Lack corresponding inspection item in standard, is a undoubtedly major hidden danger for the control of product quality.
Summary of the invention
The purpose of the present invention is in view of the shortcomings of the prior art and provide a kind of gentamicin procaine tie up B12
The HPLC-ELSD detection method of gentamicin C components content in capsule ties up B12 to gentamicin procaine using this method
The content of gentamicin C components is measured in capsule, easy to operate, and detection efficiency is high, and error is small, can quickly detect to celebrate
The content of big mycin component C, thus the effectively quality of control gentamicin procaine dimension B12 capsule.
To achieve the above object, the present invention adopts the following technical scheme that:
A kind of gentamicin procaine ties up the HPLC-ELSD detection method of gentamicin C components content in B12 capsule, including
Following steps:
(1) chromatographic condition and system suitability:
It is filler, Shiseido ACR C18 4.6 × 250mm, 5 μm of chromatographic columns, with first with octadecylsilane chemically bonded silica
Alcohol is mobile phase A, and 0.02mol/L trifluoroacetic acid is Mobile phase B, carries out gradient elution, flow velocity 1ml/min, column temperature 30 by table 1
DEG C, atomization temperature is 70 DEG C, air velocity 1.6SLM, and gentamicin standard solution chromatogram should be consistent with standard diagram;
(2) prepared by solution:
The preparation of gentamicin sulphate standard solution
Gentamicin sulphate standard items 100mg is taken, it is accurately weighed, it is placed in 10mL measuring bottle, scale is dissolved and be diluted to water, is shaken
It is even, it is accurate respectively to measure 1,3,5mL, it is diluted with water to 10mL, is shaken up, concentration, which is made, respectively may be about 1mg/mL, 3mg/mL, 5mg/
The standard solution of mL is 1., 2., 3.;
The preparation of test solution:
It takes this product content to mix, weighs in right amount, be equivalent to average loading amount, accurately weighed, precision plus water 5mL, shaking make sulfuric acid
Gentamicin dissolution, filtering take subsequent filtrate as test solution;
(3) it measures:
Precision measures standard solution, and 1., 2., 3. each 20 μ L according to above-mentioned chromatographic condition is injected separately into liquid chromatograph, records
Chromatogram calculates the equation of linear regression of standard solution each component log concentration value and corresponding peak area logarithm, phase relation
Number (r) is not less than 0.99;It takes test solution to be measured in the same method, calculates separately confession with the equation of linear regression of gentamicin each component
Amount (the C of component is corresponded in test producttcx), and calculate by following formula the content (%, u/u) of each component;
In formula, Cx is the content %, u/u of gentamicin each component;CtcxContent for each component gone out by regression equation calculation
mg/ml;It is averaged loading amount g for test sample;W is test sample sampling amount mg;V is test sample extension rate;Labelled amount is in terms of g.
C1Should be labelled amount 15.3%~28.0%, C1aIt should be 19.6%~48.0%, C of labelled amount2a+C2It should be mark
The 28.5%~63.8% of amount, four component total contents are not less than labelled amount 85%.
The invention has the benefit that
The HPLC-ELSD inspection of gentamicin C components content in a kind of gentamicin procaine dimension B12 capsule provided by the invention
Survey method, this method is easy to operate, and detection efficiency is high, and error is small, and the method for inspection is more stable, the accuracy of the method for the present invention, essence
Density, specificity, detection limit, durability etc. meet methodology validation requirement, have very strong practicability, can quickly detect
Gentamicin procaine ties up the content of gentamicin C components in B12 capsule out, to effectively control gentamicin Proca
Because tieing up the quality of B12 capsule.
Detailed description of the invention
Fig. 1 is to tie up B12 capsule sample to 47 batch gentamicin procaines using detection method to be measured
The four component total content distribution map of gentamicin sulphate obtained;
Fig. 2 is to be measured to obtain to 47 batch gentamicin procaines dimension B12 capsule sample using detection method
Gentamicin sulphate C1Constituent content distribution map;
Fig. 3 is to be measured to obtain to 47 batch gentamicin procaines dimension B12 capsule sample using detection method
Gentamicin sulphate C1aConstituent content distribution map;
Fig. 4 is to be measured to obtain to 47 batch gentamicin procaines dimension B12 capsule sample using detection method
Gentamicin sulphate C2+C2aContent distribution figure;
Fig. 5 is to tie up B12 capsule sample to the gentamicin procaine that 4 enterprises produce using detection method to survey
Surely the 4 enterprise's sample gentamicin sulphate total content average value comparison diagrams obtained;
Fig. 6 is to tie up B12 capsule sample to the gentamicin procaine that 4 enterprises produce using detection method to survey
Surely the 4 enterprise sample gentamicin sulphate C obtained1aConstituent content average value comparison diagram;
Fig. 7 is to tie up B12 capsule sample to the gentamicin procaine that 4 enterprises produce using detection method to survey
Surely the 4 enterprise sample gentamicin sulphate C obtained1Constituent content average value comparison diagram;
Fig. 8 is to tie up B12 capsule sample to the gentamicin procaine that 4 enterprises produce using detection method to survey
Surely the 4 enterprise sample gentamicin sulphate C obtained2+C2aConstituent content average value comparison diagram;
Fig. 9 is that gentamicin procaine ties up gentamicin sulphate compound mensuration typical case's map in B12 capsule.
Specific embodiment
Embodiment 1
One, a kind of gentamicin procaine ties up the HPLC-ELSD detection method of gentamicin C components content in B12 capsule, packet
Include following steps:
(1) chromatographic condition and system suitability:
It is filler, Shiseido ACR C18 4.6 × 250mm, 5 μm of chromatographic columns, with first with octadecylsilane chemically bonded silica
Alcohol is mobile phase A, and 0.02mol/L trifluoroacetic acid is Mobile phase B, carries out gradient elution, flow velocity 1ml/min, column temperature 30 by table 1
DEG C, atomization temperature is 70 DEG C, air velocity 1.6SLM, and gentamicin standard solution chromatogram should be consistent with standard diagram;
(2) prepared by solution:
The preparation of gentamicin sulphate standard solution
Gentamicin sulphate standard items 100mg is taken, it is accurately weighed, it is placed in 10mL measuring bottle, scale is dissolved and be diluted to water, is shaken
It is even, it is accurate respectively to measure 1,3,5mL, it is diluted with water to 10mL, is shaken up, concentration, which is made, respectively may be about 1mg/mL, 3mg/mL, 5mg/
The standard solution of mL is 1., 2., 3.;
The preparation of test solution:
It takes this product content to mix, weighs in right amount, be equivalent to average loading amount, accurately weighed, precision plus water 5mL, shaking make sulfuric acid
Gentamicin dissolution, filtering take subsequent filtrate as test solution;
(3) it measures:
Precision measures standard solution, and 1., 2., 3. each 20 μ L according to above-mentioned chromatographic condition is injected separately into liquid chromatograph, records
Chromatogram calculates the equation of linear regression of standard solution each component log concentration value and corresponding peak area logarithm, phase relation
Number (r) is not less than 0.99;It takes test solution to be measured in the same method, calculates separately confession with the equation of linear regression of gentamicin each component
Amount (the C of component is corresponded in test producttcx), and calculate by following formula the content (%, u/u) of each component;
In formula, Cx is the content %, u/u of gentamicin each component;CtcxContent for each component gone out by regression equation calculation
mg/ml;It is averaged loading amount g for test sample;W is test sample sampling amount mg;V is test sample extension rate;Labelled amount is in terms of g.
Two, the HPLC-ELSD of gentamicin C components content is detected in gentamicin procaine dimension B12 capsule of the present invention
The methodology validation situation of method is as follows:
1, linear relationship is investigated
Take gentamicin sulphate standard items (lot number 130326-201716, C1 content 15.9%, C1a content 15.2%, C2 content
16.9%, C2a content 10.3%;There is provided by National Institute for Food and Drugs Control) 200mg, it is accurately weighed, it is placed in 20mL measuring bottle
In, scale is dissolved and be diluted to water, is shaken up, it is accurate respectively to measure 0.5,1,2.5,5,10mL, it is diluted with water to 10mL, is shaken
It is even, be made concentration respectively may be about 0.5 μ g/mL, 1 μ g/mL, 2.5 μ g/mL, 5 μ g/mL, 10 μ g/mL linear work solution (1),
(2), (3), (4), (5).Precision measures linear work solution (1), (2), (3), (4), (5) each 20 μ L, is injected separately into liquid phase color
Spectrometer records chromatogram, carries out linear regression to corresponding peak area logarithm with each component log concentration value, the results are shown in Table 2.Knot
Fruit shows that gentamicin each component linear relationship within the scope of respective concentration is good.
2, instrument sample introduction precision is investigated
Above-mentioned linear work solution (3) is taken, 5 needle of continuous sample introduction, the RSD of 4 components is respectively 2.4%, 3.4%, 0.6%, 2.4%,
It the results are shown in Table 3.
3, stability of solution is investigated
Take (Haikou Qili Pharmaceutical Co., Ltd.'s production, lot number 171101) by the preparation of test solution in the method for the present invention
Method carries out preparing test solution, detects under the chromatographic condition limited in the methods of the invention, as the result is shown each group in solution
Point good in 12 hours internal stabilities, the RSD of tetra- components of C1a, C2, C2a, C1 is respectively 2.0%, 4.7%, 6.2%, 3.5%, knot
Fruit is shown in Table 4.
4, the rate of recovery is investigated
Take gentamicin sulphate (production of North China Hua Luan Co., Ltd, pharmacy group, lot number Q160604) in right amount, it is accurately weighed, point
It is not dissolved in water and standard solution L, M, H that concentration is about 0.5mg/mL, 1mg/mL, 1.5mg/mL is made;
The rate of recovery investigate solution L: take gentamicin procaine dimension B12 capsule (Haikou Qili Pharmaceutical Co., Ltd. production,
Lot number 171101) content mixing, it weighs appropriate (being approximately equivalent to gentamicin sulphate 5mg), accurately weighed, 10mL is added in precision
Standard solution L, shaking dissolve gentamicin sulphate, filter, take subsequent filtrate.
The rate of recovery investigates solution M: weighing content in right amount (being approximately equivalent to gentamicin sulphate 10mg), accurately weighed, essence
Close addition 10mL standard solution M, shaking dissolve gentamicin sulphate, filter, take subsequent filtrate.
The rate of recovery investigates Solution H: weighing content in right amount (being approximately equivalent to gentamicin sulphate 15mg), accurately weighed, essence
Close addition 10mL standard solution H, shaking dissolve gentamicin sulphate, filter, take subsequent filtrate.
The rate of recovery of each concentration investigates solution and prepares 3 parts in parallel, examines under the chromatographic condition limited in the methods of the invention
It surveys, the results are shown in Table 5.The result shows that the rate of recovery is good, method is feasible.
5, repeatability is investigated
Take gentamicin procaine dimension B12 capsule (Haikou Qili Pharmaceutical Co., Ltd.'s production, lot number 171101) content
Object is made repeatability by the preparation method of test solution in the method for the present invention and investigates 6 parts of solution, limits in the methods of the invention
Chromatographic condition under detect, the results are shown in Table 6.Repeatability is good as the result is shown.
6, method detection limit and quantitative limit are investigated
Three, application effect
1, using the detection side HPLC-ELSD of gentamicin C components content in gentamicin procaine of the present invention dimension B12 capsule
Method detects the 47 batch gentamicin procaines dimension B12 capsule sample that different enterprises produce, and measurement gentamicin is general
In Lu Kayinwei B12 capsule the case where gentamicin C components content,
Instrument and reagent: 380 high performance liquid chromatograph of Aglient 1260- ELSD;Electronic balance METTLER XS205DU;
Gentamicin sulphate standard items (lot number 130326-201716, C1 content 15.9%, C1a content 15.2%, C2 content 16.9%, C2a
Content 10.3%;It is provided by National Institute for Food and Drugs Control).
The sulphur for only having Chinese Pharmacopoeia to record in domestic all gentamicin sulphate preparation relevant criterions prevailing for the time being in force at present
Sour injection liquid of gentamicin has included gentamicin sulphate component check item, and provides: C1Should be labelled amount 15.3%~
28.0%, C1aIt should be 19.6%~48.0%, C of labelled amount2a+C2It should be the 28.5%~63.8% of labelled amount, four components always contain
Amount is not less than labelled amount 85%, therefore this result is evaluated in this, as reference pair.Measurement result is shown in Table 7.
2, sample measurement result is analyzed
Overall distribution situation: 47 batch sample total content average values 103.3%, content range 111.5%~93.9%;C1a content
Average value 33.2%, content range 25.6%~39.6%;C1 content average value 22.2%, content range 19.9%~27.0%;C2+
As a result C2a content average value 47.9%, content range 42.7%~54.5% meet regulation, qualification rate 100%.47 batch samples
Product total content and each component content distribution figure are shown in FIG. 1 to FIG. 4.
Data among enterprises compare: gentamicin sulphate 4 component total content Hainan day are bright to be up to 108.5%, Zhejiang Tianrui
Minimum 97.1%;C1It is trimly pharmacy 26.6%, minimum Haikou surprise power 21.8% that content is maximum;C1aMaximum content is trimly
Pharmacy 36.6%, minimum Zhejiang Tianrui 29.0%; C2+C2aContent maximum Hainan day bright 51.0%, minimum trimly pharmacy 43.1%;4
4 component total contents of enterprise's sample gentamicin sulphate are all larger than 85%, and each component content meets regulation.4 enterprise's samples are total
Content average value and the comparison of each component content average value are shown in Table 8 and Fig. 5~Fig. 8.
3, gentamicin sulphate raw material components measurement result and analysis
Version Chinese Pharmacopoeia gentamicin sulphate gentamicin C components item regulation in 2015: C1It should be 14%~22%, C1aIt should be 10%
~23%, C2+C2aIt should be 17%~36%, four component total contents must not be lower than 50.0%.7 batch sulphur that 7 enterprises are provided
Sour gentamicin raw material is measured, as the result is shown being produced by North China Hua Luan Co., Ltd, pharmacy group except the auspicious new offer in Zhejiang
Gentamicin sulphate raw material C1 content and total content be below outside prescribed limit, other API measurement results meet regulation, examine
Consider the sample that this sampling observation is not extracted into the auspicious new production in Zhejiang, and the raw material lot number provided is more early, however not excluded that enterprise does not give birth to for a long time
Production is improper to surplus stock preservation to lead to the underproof situation of assay.Measurement result is shown in Table 9.
It is above-mentioned as it can be seen that tieing up gentamicin C components content in B12 capsule using gentamicin procaine of the present invention
HPLC-ELSD detection method, easy to operate, detection efficiency is high, and error is small, and applicability is wide;It is raw to each enterprise using this method
The gentamicin procaine dimension B12 capsule of production is detected, and can fast and accurately detect that gentamicin procaine is tieed up
The content of gentamicin C components in B12 capsule, to be conducive to tie up B12 to the gentamicin procaine that each enterprise produces
The quality of capsule sample is determined.
Claims (2)
1. the HPLC-ELSD detection method of gentamicin C components content in a kind of gentamicin procaine dimension B12 capsule,
It is characterized in that, comprising the following steps:
(1) chromatographic condition and system suitability:
It is filler, Shiseido ACR C18 4.6 × 250mm, 5 μm of chromatographic columns, with first with octadecylsilane chemically bonded silica
Alcohol is mobile phase A, and 0.02mol/L trifluoroacetic acid is Mobile phase B, carries out gradient elution, flow velocity 1ml/min, column temperature 30 by table 1
℃;
(2) prepared by solution:
The preparation of gentamicin sulphate standard solution
Gentamicin sulphate standard items 100mg is taken, it is accurately weighed, it is placed in 10mL measuring bottle, scale is dissolved and be diluted to water, is shaken
It is even, it is accurate respectively to measure 1,3,5mL, it is diluted with water to 10mL, is shaken up, concentration, which is made, respectively may be about 1mg/mL, 3mg/mL, 5mg/
The standard solution of mL is 1., 2., 3.;
The preparation of test solution:
It takes this product content to mix, weighs in right amount, be equivalent to average loading amount, accurately weighed, precision plus water 5mL, shaking make sulfuric acid
Gentamicin dissolution, filtering take subsequent filtrate as test solution;
(3) it measures:
Precision measures standard solution, and 1., 2., 3. each 20 μ L according to above-mentioned chromatographic condition is injected separately into liquid chromatograph, records
Chromatogram calculates the equation of linear regression of standard solution each component log concentration value and corresponding peak area logarithm, phase relation
Number r is not less than 0.99;It takes test solution to be measured in the same method, is calculated separately with the equation of linear regression of gentamicin each component for examination
The amount C of component is corresponded in producttcx, and calculate by following formula the content Cx of each component;
In formula, Cx is the content %, u/u of gentamicin each component;CtcxContent for each component gone out by regression equation calculation
mg/ml;It is averaged loading amount g for test sample;W is test sample sampling amount mg;V is test sample extension rate;Labelled amount is in terms of g.
2. the HPLC- of gentamicin C components content in gentamicin procaine dimension B12 capsule according to claim 1
ELSD detection method, which is characterized in that in step (1) chromatographic condition and system suitability, atomization temperature is 70 DEG C, air-flow
Speed is 1.6SLM.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910230015.XA CN109917036B (en) | 2019-03-26 | 2019-03-26 | HPLC-ELSD detection method for content of gentamicin C component in gentamicin procaine vitamin B12 capsule |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910230015.XA CN109917036B (en) | 2019-03-26 | 2019-03-26 | HPLC-ELSD detection method for content of gentamicin C component in gentamicin procaine vitamin B12 capsule |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109917036A true CN109917036A (en) | 2019-06-21 |
CN109917036B CN109917036B (en) | 2022-04-01 |
Family
ID=66966746
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910230015.XA Active CN109917036B (en) | 2019-03-26 | 2019-03-26 | HPLC-ELSD detection method for content of gentamicin C component in gentamicin procaine vitamin B12 capsule |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109917036B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112730666A (en) * | 2020-12-23 | 2021-04-30 | 无锡济煜山禾药业股份有限公司 | Method for detecting content of gentamicin C1a alkali freeze-dried powder C1a |
CN113189241A (en) * | 2021-05-08 | 2021-07-30 | 河北圣雪大成制药有限责任公司 | Method for detecting gentamicin content and components in fermentation liquor by using HPLC-ELSD |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1303271A1 (en) * | 2000-07-13 | 2003-04-23 | PHARMACIA & UPJOHN COMPANY | Ophthalmic formulation of a selective cyclooxygenase-2 inhibitory drug |
CN102226790A (en) * | 2011-03-31 | 2011-10-26 | 宁波双伟制药有限公司 | Method for determining procaine hydrochloride content in gentamycin procaine vitamin B12 particle by high performance liquid chromatography |
-
2019
- 2019-03-26 CN CN201910230015.XA patent/CN109917036B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1303271A1 (en) * | 2000-07-13 | 2003-04-23 | PHARMACIA & UPJOHN COMPANY | Ophthalmic formulation of a selective cyclooxygenase-2 inhibitory drug |
CN102226790A (en) * | 2011-03-31 | 2011-10-26 | 宁波双伟制药有限公司 | Method for determining procaine hydrochloride content in gentamycin procaine vitamin B12 particle by high performance liquid chromatography |
Non-Patent Citations (3)
Title |
---|
WEI-WEI QIN等: "Simultaneous determination of procaine, lidocaine, ropivacaine, tetracaine and bupivacaine in human plasma by high-performance liquid chromatography", 《JOURNAL OF CHROMATOGRAPHY B》 * |
刘英等: "两种方法测定硫酸庆大霉素组分和有关物质的比较", 《华西药学杂志》 * |
王明娟等: "高效液相色谱-蒸发光散射检测法分析庆大霉素C组分 ", 《药物分析杂志》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112730666A (en) * | 2020-12-23 | 2021-04-30 | 无锡济煜山禾药业股份有限公司 | Method for detecting content of gentamicin C1a alkali freeze-dried powder C1a |
CN113189241A (en) * | 2021-05-08 | 2021-07-30 | 河北圣雪大成制药有限责任公司 | Method for detecting gentamicin content and components in fermentation liquor by using HPLC-ELSD |
Also Published As
Publication number | Publication date |
---|---|
CN109917036B (en) | 2022-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106383186B (en) | The HPLC analytical method of 14 kinds of vitamin contents is determined simultaneously | |
CN107643345A (en) | A kind of method of quality control of Rhizoma Gastrodiae and its medicine materical crude slice and extract | |
CN109917036A (en) | Gentamicin procaine ties up the HPLC-ELSD detection method of gentamicin C components content in B12 capsule | |
CN105388223B (en) | The assay method of residual solvent in a kind of Decitabine intermediate | |
CN108663448A (en) | Detection method in relation to substance in a kind of Amino Acid Compound Injection | |
CN113009003A (en) | Method for detecting related substances in itopride hydrochloride preparation | |
CN107315059A (en) | The content assaying method of rifampin and its impurity in a kind of rifampicin capsules | |
CN106706789A (en) | Method for detecting related substances in drotaverine hydrochloride injection by high performance liquid chromatography | |
CN102226790A (en) | Method for determining procaine hydrochloride content in gentamycin procaine vitamin B12 particle by high performance liquid chromatography | |
CN108802220A (en) | HPLC methods measure 3 kinds of naphthoquinones constituents contents and quality standard detecting method in Asian puccoon medicinal material | |
CN106525994A (en) | Method for determination of related substances of paracetamol and tramadol hydrochloride capsules | |
CN104000827B (en) | A kind of pharmaceutical composition containing active ingredient hydrochloric acid nalmefene | |
CN111398457A (en) | Method for detecting substances related to Eagliflozin influence factors under degradation condition | |
CN103901147B (en) | A kind of assay method of dripping pills of andrographolide dissolution rate | |
CN100540037C (en) | A kind of detection method of infantile lung clearing phlegm transforming preparation | |
CN106932347B (en) | A kind of mezlocillin and its quality index detection method | |
CN104678011B (en) | A kind of detection method of TONGMAIYANGXINWAN | |
CN104965031B (en) | Content measuring method for compound ketoprofen and omeprazole sustained-release capsules | |
CN109142585A (en) | A kind of detection method of sodium pantothenate isomers | |
CN108120782A (en) | A kind of assay method of ivermectin chewable tablets dissolution rate | |
CN103860461A (en) | Medicinal composition containing active component ambroxol hydrochloride | |
CN104644748B (en) | A kind of preparation method of stability-enhanced compound glycyrrhiza oral solution | |
CN107884496B (en) | Method for determining content of succinic acid in trelagliptin succinate | |
CN111239319A (en) | Method for measuring content of panax japonicus saponin IVa in laryngopharynx clearing oral liquid | |
CN102657646B (en) | Medicinal composition and preparation thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |